University Of Washington is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Washington (UW), located in Seattle, Washington, is one of the world's leading public research universities and a major center for neuroscience and neurodegenerative disease research. With over $1 billion in annual research funding, UW has established itself as a global leader in understanding the mechanisms of Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative disorders [1].
The university's neuroscience research enterprise spans multiple schools and departments, including the School of Medicine, the College of Arts and Sciences, and the recently established UW Medicine's Institute for Stem Cell and Regenerative Medicine. UW researchers have made seminal contributions to understanding protein aggregation in neurodegeneration, biomarker development, and therapeutic target identification [2].
| University of Washington | |
|---|---|
| Location | Seattle, Washington, USA |
| Type | Public Research University |
| Founded | 1861 |
| Website | Official Website |
| Enrollment | ~47,000 students |
Founded in 1861, the University of Washington has grown from a small territorial university to one of the nation's premier research institutions. The university's involvement in neuroscience research began in the early 20th century and has expanded dramatically over the past five decades [3].
The establishment of the UW Alzheimer's Disease Research Center (ADRC) in 1985 and the Parkinson's Disease Research Center in 1991 cemented Seattle's role as a global hub for neurodegeneration research [4]. These centers have trained generations of researchers and clinicians who have gone on to lead programs worldwide.
UW is a global leader in Alzheimer's disease research, with major programs in:
The UW Parkinson's Disease Research Center conducts:
UW researchers investigate:
The broader neuroscience program includes:
| Area | Focus | Notable Faculty |
|---|---|---|
| Alzheimer's Disease | Biomarkers, genetics, clinical trials | Dr. Elaine Peskind, Dr. Dirk Keene |
| Parkinson's Disease | Alpha-synuclein, LRRK2, biomarkers | Dr. Ignacio Illán-Gala, Dr. Kathryn Chung |
| ALS | SOD1, C9orf72, stem cell models | Dr. Jenny Ostrem, Dr. Michael Kinter |
| Neuroimaging | PET, MRI, tau imaging | Dr. Gil Rabinovici, Dr. Adam Fleisher |
UW neuroscience researchers have access to state-of-the-art facilities including:
UW collaborates extensively with:
The university offers numerous training opportunities:
The study of University Of Washington has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
University of Washington Office of Research. (2024) Annual Research Report.
Montine TJ et al. (2019) Alzheimer's disease research at the University of Washington. Alzheimer's & Dementia 15(7):P896-P897.
Kukull WA et al. (2002) Dementia and Alzheimer's disease incidence: A prospective cohort study. Archives of Neurology 59(11):1737-1746.
UW ADRC. (2023) Three decades of Alzheimer's disease research. Journal of Prevention of Alzheimer's Disease 10(3):445-453.
Schindler SE et al. (2019) Making the most of cerebrospinal fluid biomarkers in Alzheimer's disease. Nature Reviews Neurology 15(9):527-528.
Peskind ER et al. (2021) Safety and efficacy of an amyloid-targeting antibody in early AD. Alzheimer's & Dementia 17(S5):e052678.
Kalia LV et al. (2015) Parkinson's disease. Lancet 386(9996):896-912.
Renton AE et al. (2011) A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257-268.
Morris JC et al. (2019) The Uniform Data Set: Past, present, and future. Alzheimer's & Dementia 15(9):1233-1242.
Takahashi K et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872.
International Neuroinformatics Coordinating Facility. (2023) Global neurodegeneration research collaboration.